Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 19 2 2019
medline: 11 2 2020
entrez: 19 2 2019
Statut: ppublish

Résumé

Hospital-onset bacteremia and fungemia (HOB), a potential measure of healthcare-associated infections, was evaluated in a pilot study among 60 patients across 3 hospitals. Two-thirds of all HOB events and half of nonskin commensal HOB events were judged as potentially preventable. Follow-up studies are needed to further develop this measure.

Identifiants

pubmed: 30773166
pii: S0899823X18003392
doi: 10.1017/ice.2018.339
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

358-361

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI079040
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Raymund B Dantes (RB)

Division of Hospital Medicine, Department of Medicine,Emory University School of Medicine,Atlanta, Georgia.

Clare Rock (C)

Division of Infectious Diseases, Department of Medicine,Johns Hopkins University School of Medicine,Baltimore, Maryland.

Aaron M Milstone (AM)

Division of Infectious Diseases, Department of Pediatrics,Johns Hopkins University School of Medicine,Baltimore, Maryland.

Jesse T Jacob (JT)

Division of Infectious Diseases, Department of Medicine,Emory University School of Medicine,Atlanta, Georgia.

Sheri Chernetsky-Tejedor (S)

Division of Hospital Medicine, Department of Medicine,Emory University School of Medicine,Atlanta, Georgia.

Anthony D Harris (AD)

University of Maryland School of Medicine,Baltimore, Maryland,for the CDC Prevention Epicenter Program.

Surbhi Leekha (S)

University of Maryland School of Medicine,Baltimore, Maryland,for the CDC Prevention Epicenter Program.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH